Literature DB >> 22501017

Glioma stem cells: their role in chemoresistance.

Ryosuke Yamada, Ichiro Nakano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22501017     DOI： 10.1016/j.wneu.2012.01.004

Source DB:  PubMed          Journal:  World Neurosurg        ISSN： 1878-8750            Impact factor:   2.104


× No keyword cloud information.
  14 in total

1.  Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity.

Authors:  S Sharif; M H Ghahremani; M Soleimani
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

2.  Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.

Authors:  Daniela A Bota; Daniela Alexandru-Abrams; Chrystel Pretto; Florence M Hofman; Thomas C Chen; Beverly Fu; Jose A Carrillo; Virgil Ejc Schijns; Apostolos Stathopoulos
Journal:  Perm J       Date:  2015-03-01

3.  Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.

Authors:  Chiara Riganti; Iris Chiara Salaroglio; Valentina Caldera; Ivana Campia; Joanna Kopecka; Marta Mellai; Laura Annovazzi; Amalia Bosia; Dario Ghigo; Davide Schiffer
Journal:  Neuro Oncol       Date:  2013-07-28       Impact factor: 12.300

4.  The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.

Authors:  Barbara Banelli; Elisa Carra; Federica Barbieri; Roberto Würth; Federica Parodi; Alessandra Pattarozzi; Roberta Carosio; Alessandra Forlani; Giorgio Allemanni; Daniela Marubbi; Tullio Florio; Antonio Daga; Massimo Romani
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.

Authors:  Andrej Besse; Jiri Sana; Pavel Fadrus; Ondrej Slaby
Journal:  Tumour Biol       Date:  2013-04-09

6.  miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas.

Authors:  Ju Cheol Son; Hyoung Oh Jeong; Deaui Park; Sang Gyoon No; Eun Kyeong Lee; Jaewon Lee; Hae Young Chung
Journal:  Cancer Inform       Date:  2017-04-12

7.  Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes.

Authors:  Suojun Zhang; Ruifan Xie; Feng Wan; Fei Ye; Dongsheng Guo; Ting Lei
Journal:  Oncol Lett       Date:  2013-10-11       Impact factor: 2.967

8.  Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity.

Authors:  Jessian L Munoz; Sarah A Bliss; Steven J Greco; Shakti H Ramkissoon; Keith L Ligon; Pranela Rameshwar
Journal:  Mol Ther Nucleic Acids       Date:  2013-10-01       Impact factor: 10.183

9.  RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.

Authors:  Nis David Giladi; Amotz Ziv-Av; Hae Kyung Lee; Susan Finniss; Simona Cazacu; Cunli Xiang; Hiba Waldman Ben-Asher; Ana deCarvalho; Tom Mikkelsen; Laila Poisson; Chaya Brodie
Journal:  Oncotarget       Date:  2015-09-08

10.  RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK.

Authors:  Amotz Ziv-Av; Nissim David Giladi; Hae Kyung Lee; Simona Cazacu; Susan Finniss; Cunli Xiang; Maor H Pauker; Mira Barda-Saad; Laila Poisson; Chaya Brodie
Journal:  Oncotarget       Date:  2015-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.